TANG Wei

Biography

Dr. Tang Wei earned her B.Sc. in Chemistry from the University of Science and Technology of China, followed by a Ph.D. in Chemistry from the University of Georgia, USA. She subsequently completed a postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. In 2021, she joined the Department of Pharmacy and Pharmaceutical Sciences at the National University of Singapore (NUS) as an Assistant Professor.

Her research group is dedicated to advancing drug delivery technologies to improve safety and efficacy for early detection, precise patient stratification, and personalized therapy for cancer and other critical healthcare challenges. The group’s work integrates chemistry, biomaterials science, nanomedicine, molecular imaging, and immunoengineering, with a focus on understanding the relationship between in vivo drug transport and biological barriers.

Research Focus

• Precision Nanomedicine: Designing and synthesizing smart nanoparticles to deliver imaging probes, chemotherapeutics, nucleic acids (mRNA, siRNA, miRNA), and immunomodulators, targeting the tumor microenvironment for personalized therapy.
  
• Engineering Immunotherapy: Developing biomaterial-inspired strategies to modulate cancer–immune cell interactions, enabling effective vaccine delivery and immunotherapy.
• Translational Delivery: Innovating multidisciplinary approaches to enhance the transport of diagnostics and therapeutics across biological barriers such as the respiratory mucosa, small intestine, and skin.

PUBLICATIONS

Google Scholar - Wei TANG

ORCID - Wei TANG